Pfizer Earnings Fall 18% On Loss Of Zyrtec, Norvasc
This article was originally published in The Pink Sheet Daily
Executive Summary
First quarter revenues also are down 5 percent to $12.5 billion, but Lyrica and Chantix see gains.
You may also be interested in...
Chantix Banned For Pilots; Watchdog Report Cites More Risk
Pfizer’s anti-smoking drug topped adverse-events reports in the fourth quarter of last year, nonprofit says.
Chantix Banned For Pilots; Watchdog Report Cites More Risk
Pfizer’s anti-smoking drug topped adverse-events reports in the fourth quarter of last year, nonprofit says.
Pfizer Wins Lipitor Reversal
Patent office's decision blocks generic atorvastatin until 2010.